Median Nerve Compression

3

Review clinical trials related to Median Nerve Compression. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Median Nerve Cross-Sectional Area and Body Weight in Carpal Tunnel Syndrome

This study aims to evaluate the diagnostic accuracy of ultrasonographic measurements of the median nerve in patients with Carpal Tunnel Syndrome (CTS). While ultrasound is a common diagnostic tool, various physical factors can influence its results. The researchers will investigate how a patient's absolute body weight and Body Mass Index (BMI) affect the size of the median nerve cross-sectional area across different stages of disease severity. The goal is to determine if absolute body weight plays a 'masking' role that could lead to more precise diagnostic interpretations in clinical practice.

Participants needed: 120
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Kayseri City HospitalUpdated: Apr 2, 2026
Eligibility criteria

Patients aged between 18 and 75 years. [+4]

Secondary causes of CTS (e.g., Diabetes Mellitus, Hypothyroidism, Rheumatoid -Ar... [+5]

Status: Not yet recruiting

Efficacy of Proximal Median Nerve Release

A multi-center randomized controlled clinical trial which determines the efficacy of proximal median nerve release in patients with persistent proximal median nerve compression. The primary outcome is patient reported improvement of symptoms on a 7-point Likert scale at 6 months after the randomization to treatment group.

Participants needed: 160
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Tampere University HospitalUpdated: Mar 19, 2026Locations: 2
Eligibility criteria

Clinically diagnosed PMNC [+6]

Nerve root disorder findings in ENMG [+7]

Status: Not yet recruiting

Magnetotherapy in Carpal Tunnel Syndrome: Randomized Controlled Study

This study is designed to investigate the effectiveness of low-frequency pulsed electromagnetic field therapy in individuals diagnosed with mild-to-moderate carpal tunnel syndrome (CTS). This double-blind, randomized controlled trial will randomly assign participants into three groups: Group 1: Active magnetotherapy Group 2: Placebo magnetotherapy (treatment using an identical device that does not generate a magnetic field) Group 3: Routine (conservative) treatment group All participants will receive a standard nighttime wrist splint and a standardized nerve and tendon gliding exercise protocol. Magnetic field applications will be administered five days per week for a total of 15 sessions. Assessments will be conducted at baseline (T0), at the end of treatment (T1 - Week 3), at 1 month (T2), and at 3 months (T3). The primary outcome measures include the Boston Carpal Tunnel Questionnaire (BCTQ), pain intensity assessed by the Visual Analog Scale (VAS), functional status measured by QuickDASH, median nerve cross-sectional area assessed by ultrasonography, sensory function evaluated using the Semmes-Weinstein monofilament test, grip strength measured by dynamometry, and clinical test results (Tinel and Phalen tests). Secondary outcomes include sleep quality assessed by the Pittsburgh Sleep Quality Index (PSQI) and patient satisfaction. This study aims to contribute to the scientific evidence regarding the effectiveness of magnetotherapy as a non-invasive treatment option for carpal tunnel syndrome.

Participants needed: 60
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Fatih Sultan Mehmet Training and Research HospitalUpdated: Feb 27, 2026Locations: 1
Eligibility criteria

Adults aged between 18 and 65 years.

Severe carpal tunnel syndrome confirmed electrophysiologically by electromyograp...